cornichon family member 1Genealiases: CNIH · CNIH-1 · CNIL · TGAM77
Q-omics provides the consensus-scored CNIH1 profile across patient tissues and cancer cell-line models. CNIH1 expression is associated with patient survival in 24 of 34 cancer types, with the highest sampling consensus in CESC. Among the 18 cancer types available for tumor–normal comparison, CNIH1 is differentially expressed in 14, with the highest sampling consensus in HNSC. Additionally, CNIH1 RNA expression shows 19,042 significant gene co-expression associations, with the highest sampling consensus in ACC. Together, these results highlight CESC, HNSC, and ACC as cancer lineages where CNIH1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for CNIH1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes CNIH1 survival associations across molecular data types. CNIH1 RNA expression shows survival associations in the most cancer types (24), followed by mutation status (1) and mass-spec protein abundance (3). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible CNIH1 RNA expression–survival associations across cancer types. High CNIH1 expression shows unfavorable associations in CESC, ACC, LUAD, HNSC and BLCA, but favorable associations in KIRC. The CESC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify CESC as the clearest survival context for CNIH1 RNA expression.
This table summarizes CNIH1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 14, while mass-spec protein shows differences in 1. The strongest signals are observed in HNSC for RNA and OV for protein.
This table ranks reproducible tumor–normal expression differences for CNIH1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. CNIH1 shows lower tumor expression in KICH and UCEC and higher tumor expression in HNSC, LUAD, ESCA and STAD. The HNSC box plot shows higher CNIH1 RNA expression in tumor versus normal tissue (log2 FC = +1.007, t-test p < 0.001).
This table shows molecular features associated with CNIH1 in patient tissues and cancer cell lines. In patient samples, CNIH1 shows the broadest associations at the RNA and protein expression levels, with ACC recurring as the lineage with the largest associated feature set. In cancer cell lines, CNIH1 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in CNS, while CRISPR and shRNA rows add functional-dependency signals in UPPER_AERODIGESTIVE_TRACT and LUNG_SCLC.
